A detailed history of Geode Capital Management, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,746,894 shares of ORGO stock, worth $5.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,746,894
Previous 1,748,523 0.09%
Holding current value
$5.21 Million
Previous $4.97 Million 1.49%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$2.28 - $3.03 $3,714 - $4,935
-1,629 Reduced 0.09%
1,746,894 $4.89 Million
Q1 2024

May 13, 2024

BUY
$2.61 - $4.49 $134,819 - $231,930
51,655 Added 3.04%
1,748,523 $4.97 Million
Q4 2023

Feb 13, 2024

BUY
$1.97 - $4.21 $127,667 - $272,833
64,806 Added 3.97%
1,696,868 $6.94 Million
Q3 2023

Nov 13, 2023

BUY
$2.34 - $4.43 $193,967 - $367,211
82,892 Added 5.35%
1,632,062 $5.19 Million
Q2 2023

Aug 11, 2023

BUY
$1.9 - $4.3 $69,226 - $156,670
36,435 Added 2.41%
1,549,170 $5.14 Million
Q1 2023

May 15, 2023

BUY
$1.89 - $2.93 $87,015 - $134,897
46,040 Added 3.14%
1,512,735 $3.22 Million
Q4 2022

Feb 13, 2023

BUY
$2.48 - $3.43 $378,204 - $523,081
152,502 Added 11.6%
1,466,695 $3.95 Million
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $30,137 - $61,715
9,598 Added 0.74%
1,314,193 $4.26 Million
Q2 2022

Aug 12, 2022

SELL
$4.74 - $8.15 $127,302 - $218,884
-26,857 Reduced 2.02%
1,304,595 $6.37 Million
Q1 2022

May 13, 2022

BUY
$6.47 - $9.57 $2.46 Million - $3.63 Million
379,505 Added 39.87%
1,331,452 $10.1 Million
Q4 2021

Feb 11, 2022

BUY
$9.02 - $13.5 $509,503 - $762,561
56,486 Added 6.31%
951,947 $8.8 Million
Q3 2021

Nov 12, 2021

BUY
$13.71 - $17.18 $383,523 - $480,593
27,974 Added 3.22%
895,461 $12.8 Million
Q2 2021

Aug 13, 2021

BUY
$14.92 - $23.23 $2.05 Million - $3.19 Million
137,375 Added 18.82%
867,487 $14.4 Million
Q1 2021

May 12, 2021

BUY
$7.33 - $21.06 $107,457 - $308,739
14,660 Added 2.05%
730,112 $13.3 Million
Q4 2020

Feb 12, 2021

BUY
$3.63 - $7.53 $1.22 Million - $2.52 Million
335,098 Added 88.1%
715,452 $5.39 Million
Q3 2020

Nov 13, 2020

BUY
$3.29 - $4.58 $39,779 - $55,376
12,091 Added 3.28%
380,354 $1.46 Million
Q2 2020

Aug 13, 2020

BUY
$2.86 - $4.61 $360,811 - $581,588
126,158 Added 52.11%
368,263 $1.41 Million
Q1 2020

May 14, 2020

BUY
$2.92 - $5.31 $127,095 - $231,123
43,526 Added 21.92%
242,105 $781,000
Q4 2019

Feb 13, 2020

BUY
$4.7 - $8.11 $105,477 - $182,004
22,442 Added 12.74%
198,579 $955,000
Q3 2019

Nov 12, 2019

SELL
$3.57 - $8.09 $28,460 - $64,493
-7,972 Reduced 4.33%
176,137 $1.16 Million
Q2 2019

Aug 14, 2019

BUY
$6.58 - $8.69 $330,960 - $437,089
50,298 Added 37.59%
184,109 $1.4 Million
Q1 2019

May 14, 2019

BUY
$7.05 - $150.0 $943,367 - $20.1 Million
133,811 New
133,811 $1 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $390M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.